5 completed, 1 withdrawn. 3 Phase 3, 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
| Phase 1 | 2 | Completed 1, Withdrawn 1 |
| Phase 2 | 1 | Completed 1 |
Follow sulopenem: new trials by email Literature Review of sulopenem trials Research Report on sulopenem
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Oral Sulopenem Versus Amoxicillin/Clavulanate for Uncomplicated Urinary Tract Infection in Adult Women Sulopenem etzadroxil/probenecid, Amoxicillin/clavulanate - Urinary Tract Infections, Cystitis | Phase 3 | Completed | Iterum Therapeutics, International Limited | 2229 | 2022-10-18 | 2024-11-20 |
| Safety, Tolerability, and Pharmacokinetics of Sulopenem in Adolescents Sulopenem - Urinary Tract Infections, Pyelonephritis Acute | Phase 1 | Withdrawn | Iterum Therapeutics, International Limited | 2021-04-30 | 2022-06-13 | |
| Sulopenem Followed by Sulopenem-etzadroxil/Probenecid vs Ertapenem Followed by Cipro for Complicated UTI in Adults Sulopenem, Sulopenem-Etzadroxil/Probenecid, Ertapenem - Complicated Urinary Tract Infections | Phase 3 | Completed | Iterum Therapeutics, International Limited | 1395 | 2018-09-18 | 2020-12-29 |
| Sulopenem Versus Ertapenem for Complicated Intra-abdominal Infection (cIAI) Ertapenem, Sulopenem-Etzadroxil/Probenecid, Ciprofloxacin - Intra Abdominal Infections | Phase 3 | Completed | Iterum Therapeutics, International Limited | 674 | 2018-09-18 | 2020-12-01 |
| A Study Of Intravenous Sulopenem And Oral PF-03709270 In Community Acquired Pneumonia That Requires Hospitalization sulopenem and PF-03709270, Sulopenem and PF-03709270, Ceftriaxone and amoxicillin/clavulanate - Pneumonia, Bacterial | Phase 2 | Completed | Pfizer | 35 | 2009-01-01 | 2016-03-10 |
| A Study To Investigate The Pharmacokinetics, Safety And Tolerability Of An Intravenous And Oral Form Of A Compound In Subjects With Varying Degrees Of Renal Impairment And Normal Renal Function CP-70,429 and PF-03709270 - Pneumonia | Phase 1 | Completed | Pfizer | 29 | 2008-11-01 | 2016-03-11 |
Intraabdominal Infections (2) · Urinary Tract Infections (2) · Cystitis (1) · Pneumonia (1) · Pneumonia, Bacterial (1)
Iterum Therapeutics, International Limited (4) · Pfizer (2)
United States (6) · Estonia (2) · Georgia (2) · Hungary (2) · Latvia (2) · Poland (2) · Australia (1) · Belgium (1) · Bulgaria (1) · Canada (1) · South Korea (1)
Sailaja Puttagunta, MD (1) · Steven I Aronin, MD (1)
2008 (1), 2009 (1)